Gender Treatments for Children (WA)

Write your own email to the federal health minister ([email protected]) and your state premier and state health minister:

SA: [email protected], [email protected]
NSW: [email protected], [email protected]
ACT: [email protected], [email protected]
TAS: [email protected]
WA: [email protected], [email protected]
QLD: [email protected], [email protected]
VIC: [email protected], [email protected]
NT: [email protected], [email protected]

In your email ensure that you are polite and respectful. You may wish to consider the following information:

Queensland has made a landmark call by pausing the prescription of puberty blockers and cross-sex hormones for new patients under 18. This action follows shocking revelations that the Cairns Sexual Health Service had been prescribing these experimental, life-altering treatments to children as young as 12— sometimes without evidence of parental consent or proper medical oversight.

The Queensland Government’s decision is a major victory for child safety and accountability. But this must be just the beginning. Queensland’s pause is a first step—but it is far from enough. We need all states and territories to follow suit.

I am
Male
Female
Your name
Your age
Street name + suburb (street number not required)
Your email
Keep me up to date with ACL campaigns
Select all that apply
or click Continue if none do.
I am a parent
I am a grandparent
I am a concerned constituent
I am a healthcare professional
Select all that are important to you
about this proposal:
The government is favouring ideology over evidence
The long-term impacts of cross-sex hormones
Children cannot give informed consent
That puberty blockers are experimental
Loading...
Here is the generated email:
To:
Subject

Body


Clicking this should open this in your default email program.

Not opening? Click here

Still not opening? You can copy and paste the text into an email program you like to use.


Still not working?
Click below and we will send your
email for you.

Thank you!

We have received your email which we will forward to the relevant email addresses.

Signup to receive updates from ACL

We only collect your name and email address if you give us permission. Issue-specific questions are only used to generate a suggested email. See our privacy policy.